We can only imagine what’s happening at the Medtronic Diabetes headquarters in sunny California. Now that Animas has surrendered, Tandem is on its last few shekels and will soon join Animas, Cozmo, Asante and Roche in the insulin pump scrapyard. Now it would not surprise us at all if there isn’t some high fiving in the hallways, some serious fist bumps and lots of Kool Aid drinking. Yes, it sure is good to go from having a monopoly to almost 90% market share.
Yes, we’re sure these good people feel pretty good, the came, they plundered and . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.